CN110542675B - 细胞凋亡检测方法及细胞凋亡检测试剂盒 - Google Patents
细胞凋亡检测方法及细胞凋亡检测试剂盒 Download PDFInfo
- Publication number
- CN110542675B CN110542675B CN201910941568.6A CN201910941568A CN110542675B CN 110542675 B CN110542675 B CN 110542675B CN 201910941568 A CN201910941568 A CN 201910941568A CN 110542675 B CN110542675 B CN 110542675B
- Authority
- CN
- China
- Prior art keywords
- fluorescent dye
- ome
- apoptosis
- cells
- cell sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000006907 apoptotic process Effects 0.000 title claims abstract description 139
- 238000001514 detection method Methods 0.000 title claims abstract description 65
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 180
- 238000004458 analytical method Methods 0.000 claims abstract description 45
- 238000001917 fluorescence detection Methods 0.000 claims abstract description 24
- 230000001640 apoptogenic effect Effects 0.000 claims abstract description 19
- 238000004043 dyeing Methods 0.000 claims abstract description 11
- 230000001338 necrotic effect Effects 0.000 claims abstract description 7
- 239000012192 staining solution Substances 0.000 claims description 33
- 238000010186 staining Methods 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 238000003556 assay Methods 0.000 claims description 16
- 238000003384 imaging method Methods 0.000 claims description 16
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical group C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 claims description 13
- 230000005284 excitation Effects 0.000 claims description 10
- QBKMWMZYHZILHF-UHFFFAOYSA-L Po-Pro-1 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)C)C=C1 QBKMWMZYHZILHF-UHFFFAOYSA-L 0.000 claims description 8
- QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 claims description 8
- 239000000975 dye Substances 0.000 claims description 8
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 claims description 6
- 108700012813 7-aminoactinomycin D Proteins 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 2
- 241000764238 Isis Species 0.000 claims 1
- 230000017074 necrotic cell death Effects 0.000 abstract description 24
- 230000035945 sensitivity Effects 0.000 abstract description 8
- 238000013537 high throughput screening Methods 0.000 abstract description 4
- 230000011218 segmentation Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 196
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 32
- 235000003642 hunger Nutrition 0.000 description 21
- 230000037351 starvation Effects 0.000 description 20
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 230000001939 inductive effect Effects 0.000 description 15
- 230000032050 esterification Effects 0.000 description 11
- 238000005886 esterification reaction Methods 0.000 description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 description 10
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 description 10
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 description 10
- 108090000672 Annexin A5 Proteins 0.000 description 9
- 102000004121 Annexin A5 Human genes 0.000 description 9
- 239000006143 cell culture medium Substances 0.000 description 9
- 238000000684 flow cytometry Methods 0.000 description 7
- 210000004940 nucleus Anatomy 0.000 description 7
- 102000035195 Peptidases Human genes 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 238000007447 staining method Methods 0.000 description 6
- 239000012148 binding buffer Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 239000004365 Protease Substances 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 102000047934 Caspase-3/7 Human genes 0.000 description 3
- 108700037887 Caspase-3/7 Proteins 0.000 description 3
- 108010040476 FITC-annexin A5 Proteins 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 102000011727 Caspases Human genes 0.000 description 2
- 108010076667 Caspases Proteins 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- 101000780122 Homo sapiens Annexin A5 Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 210000001700 mitochondrial membrane Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000025915 regulation of apoptotic process Effects 0.000 description 2
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 2
- 229960004528 vincristine Drugs 0.000 description 2
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 2
- 102000000412 Annexin Human genes 0.000 description 1
- 108050008874 Annexin Proteins 0.000 description 1
- 238000010152 Bonferroni least significant difference Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910941568.6A CN110542675B (zh) | 2019-09-30 | 2019-09-30 | 细胞凋亡检测方法及细胞凋亡检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910941568.6A CN110542675B (zh) | 2019-09-30 | 2019-09-30 | 细胞凋亡检测方法及细胞凋亡检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110542675A CN110542675A (zh) | 2019-12-06 |
CN110542675B true CN110542675B (zh) | 2021-12-14 |
Family
ID=68715142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910941568.6A Active CN110542675B (zh) | 2019-09-30 | 2019-09-30 | 细胞凋亡检测方法及细胞凋亡检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110542675B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114324274B (zh) * | 2021-12-29 | 2024-01-05 | 重庆市人口和计划生育科学技术研究院 | 特异性核酸荧光染色反应液及其在精子dna完整性检测中的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101893572A (zh) * | 2010-06-22 | 2010-11-24 | 广西医科大学 | 细胞早期凋亡的检测方法 |
CN103712967A (zh) * | 2013-12-27 | 2014-04-09 | 首都医科大学附属北京友谊医院 | 检测nk细胞活性的方法 |
CN110018143A (zh) * | 2019-03-29 | 2019-07-16 | 深圳大学 | 检测甲藻细胞凋亡的方法 |
CN110231275A (zh) * | 2019-05-20 | 2019-09-13 | 西安交通大学 | 一种基于流式细胞术检测nk细胞杀伤活性的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10313636A1 (de) * | 2003-03-26 | 2004-10-14 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Verwendung von Wirksubstanzen zur Vorbeuge oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen |
FR2878522B1 (fr) * | 2004-12-01 | 2008-04-18 | Merck Sante Soc Par Actions Si | Nouveaux inhibiteurs specifiques de la caspas-10 |
-
2019
- 2019-09-30 CN CN201910941568.6A patent/CN110542675B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101893572A (zh) * | 2010-06-22 | 2010-11-24 | 广西医科大学 | 细胞早期凋亡的检测方法 |
CN103712967A (zh) * | 2013-12-27 | 2014-04-09 | 首都医科大学附属北京友谊医院 | 检测nk细胞活性的方法 |
CN110018143A (zh) * | 2019-03-29 | 2019-07-16 | 深圳大学 | 检测甲藻细胞凋亡的方法 |
CN110231275A (zh) * | 2019-05-20 | 2019-09-13 | 西安交通大学 | 一种基于流式细胞术检测nk细胞杀伤活性的方法 |
Non-Patent Citations (3)
Title |
---|
"Caspase 3 Inhibition Improves Survival and Reduces Early Graft Injury After Ischemia and Reperfusion in Rat Liver Transplantation";Thomas H. J. Mueller et al.;《Transplantation》;20041115;第78卷(第9期);第1267-1273页 * |
"Cleavage of epidermal growth factor receptor by caspase during apoptosis is independent of its internalization";Y-Y He et al.;《Oncogene》;20051017;第1521-1531页 * |
"Regulation of caspase-3 processing by cIAP2 controls the switch between pro-inflammatory activation and cell death in microglia";E Kavanagh et al.;《Cell Death and Disease》;20141211;第1-9页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110542675A (zh) | 2019-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2126962C1 (ru) | Способ обнаружения микроорганизмов в образце, способ определения чувствительности микроорганизмов к антибиотику и система для реализации таких способов | |
US4581223A (en) | Individual leukocyte determination by means of differential metachromatic dye sorption | |
JP4918281B2 (ja) | 尿中有形成分分析装置 | |
US6656683B1 (en) | Laser scanning cytology with digital image capture | |
JP2002541494A (ja) | 組織学的再構成と自動画像分析 | |
WO2014133160A1 (ja) | 尿検体分析装置及び尿検体分析方法 | |
CN112813133B (zh) | 一种细胞杀伤效力的检测方法、系统及其应用 | |
EP2630492B1 (en) | Internal focus reference beads for imaging cytometry | |
US6803208B2 (en) | Automated epifluorescence microscopy for detection of bacterial contamination in platelets | |
CN110018143B (zh) | 检测甲藻细胞凋亡的方法 | |
CN110542675B (zh) | 细胞凋亡检测方法及细胞凋亡检测试剂盒 | |
Cornelisse et al. | A new type of two-color fluorescence staining for cytology specimens. | |
TWI770823B (zh) | 尿沉渣檢查用之超活體染色液、尿沉渣檢查方法、於尿沉渣檢查中之夾雜物的染色抑制方法、提高於尿沉渣檢查中之稀有成分的檢定力之方法 | |
Brama et al. | Standard fluorescent proteins as dual-modality probes for correlative experiments in an integrated light and electron microscope | |
US7371565B2 (en) | Apparatus and method for measuring intracellular reactions | |
CN115372107A (zh) | 前处理试剂及制备方法和细胞染色方法及前处理方法 | |
CN111693353A (zh) | 一种集成有染色功能的显微镜镜检的检测系统 | |
Kiewisz et al. | High-throughput screening of mitotic mammalian cells for electron microscopy using classic histological dyes | |
Driouchi et al. | Oblique Line Scan Illumination Enables Expansive, Accurate and Sensitive Single Protein Measurements in Solution and in Living Cells | |
CN112903634A (zh) | 对免疫细胞进行细胞数、活力或凋亡测定的高精密度方法 | |
JP2004535807A (ja) | 間期核の蛍光インサイチューハイブリダイゼーションによって染色体間不均衡を検出する方法およびシステム | |
CN112285082A (zh) | 一种基于细胞直径评价细胞杀伤效力的方法及其应用 | |
Feng et al. | Comparing techniques for detecting the number of somatic cells in raw milk | |
Avci et al. | Cell counting platform for life science applications | |
Remenyi et al. | On-demand Labeling of SNAP-tagged Viral Protein for Pulse-Chase Imaging, Quench-Pulse-Chase Imaging, and Nanoscopy-based Inspection of Cell Lysates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200122 Address after: 510663 innovation building, 182 science Road, Guangzhou Development Zone, Guangdong, Guangzhou, C3-13 Applicant after: GUANGZHOU RIBOBIO Co.,Ltd. Applicant after: Guangzhou Rui Bo Biotechnology Co.,Ltd. Address before: 510663 innovation building, 182 science Road, Guangzhou Development Zone, Guangdong, Guangzhou, C3-13 Applicant before: GUANGZHOU RIBOBIO Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Cell apoptosis detection methods and cell apoptosis detection kit Effective date of registration: 20230615 Granted publication date: 20211214 Pledgee: CITIC Bank Co.,Ltd. Guangzhou Branch Pledgor: GUANGZHOU RIBOBIO Co.,Ltd. Registration number: Y2023980044095 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240508 Address after: 510530 No.7, tungda street, Science City, Huangpu District, Guangzhou City, Guangdong Province Patentee after: GUANGZHOU RIBOBIO Co.,Ltd. Country or region after: China Address before: 510663 C3-13, innovation building, 182 science Avenue, Guangzhou Development Zone, Guangzhou City, Guangdong Province Patentee before: GUANGZHOU RIBOBIO Co.,Ltd. Country or region before: China Patentee before: Guangzhou Rui Bo Biotechnology Co.,Ltd. |